Q1 2021 Sanofi SA Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Sanofi First Quarter 2021 Earnings Call. I would now like to turn the call over to Eva Schaefer-Jansen, Head of Sanofi Investor Relations. Please go ahead, Eva.
Good morning, and good afternoon to everyone. Thank you for joining us to review Sanofi's 2021 first quarter results followed by a Q&A session. As usual, you can find the slides to this earnings call on the Investors home page on our website at sanofi.com.
Next slide. Moving to Slide 2. I would like to remind you that information presented in this call contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d'Enregistrement Universel for a description of these risk factors.
With that, on Slide 3, I would like to introduce our speakers for today. So we have Paul Hudson, Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |